BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Bio NC

  3 Small-Cap Biotechs With the Most Promising New Antibiotics in Clinical Trials

  New antibiotic development seems to go through cycles and many large companies have stayed away from antibiotics or abandoned efforts, despite a growing need for new antibiotics.

  October 26, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  FDA Calls BioMarin’s Hemophilia A Drug a Breakthrough

  BioMarin announced that the FDA granted its valoctocogene roxaparvovec for Hemophilia A Breakthrough Therapy Designation.

  October 26, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Deals

  Siemens Summons Three Banks for IPO of Healthineers Unit

  Siemens AG is looking to take its Healthineers unit public.

  October 26, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Gilead HCV Woes Continue and Investors are Spooked

  Gilead continues to see serious revenue declines in its hepatitis C marketshare, a space it has dominated for several years.

  October 26, 2017

   · 

  2 min read

   · 

  Alex Keown
• Drug Development

  Neurana Pharma Reports Successful Results in Study Designed to Confirm the Non-Sedative Effects of Tolperisone, a Novel Skeletal Muscle Relaxant

  Neurana Pharma today announced the successful top-line results from a clinical trial designed to confirm the non-sedative effects of tolperisone.

  October 26, 2017

   · 

  4 min read
• Pharm Country

  BD Announces Extension of Exchange Offers and Consent Solicitations for C. R. Bard Notes

  BD announced today that BD has amended the Exchange Offers and Consent Solicitations to extend the expiration date of the Exchange Offers and Consent Solicitations.

  October 26, 2017

   · 

  8 min read
• Business

  Intec Pharma Names Walt Linscott as Chief Administrative Officer

  Intec Pharma today announced it has named Mr. Walt Linscott to the position of Chief Administrative Officer.

  October 26, 2017

   · 

  4 min read
• Business

  Excellent Results in Inhibiting Shingles Virus in Human Skin: NanoViricides Extends Agreement With SUNY Upstate Medical Center

  NanoViricides announced today that it has extended its agreement with SUNY Upstate Medical Center for further testing of its nanoviricides drug candidates against varicella-zoster virus (VZV), the shingles virus, that causes debilitating infection of human skin.

  October 26, 2017

   · 

  3 min read
• Business

  ArQule to Report Third Quarter 2017 Financial Results on November 9, 2017

  ArQule, Inc. today announced it will report financial results for the third quarter 2017 before the market opens on Thursday, November 9, 2017.

  October 26, 2017

   · 

  2 min read
• Antibe Therapeutics Announces Key US Distribution Partnership for Its Subsidiary, Citagenix

  Antibe Therapeutics Inc.is pleased to announce that its subsidiary, Citagenix Inc., has been selected by Darby Dental Supply, LLC (“Darby Dental”) to be its supplier of premium bone grafting and tissue regeneration products.

  October 26, 2017

   · 

  3 min read